Form 4 for RMD ResMed|
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001127602-21-029582 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-18 | 2021-11-16+ | RMD | Sandercock Brett | CFO | A - Grant | $241.06 | +21.5K | 106.4K | +25% | +$5.19M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-11-16 | A | A | 20,360 | $254.81 | 105,193 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2021-11-18 | A | A | 1,161 | $0.00 | 106,354 | D | — | — |